NeuroPace, Inc.NPCENASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 45 | 46 | 65 |
| Gross Profit | 33 | 32 | 48 |
| Operating Income | -24 | -41 | -27 |
| Net Income | -36 | -47 | -33 |
| EBITDA | -28 | -37 | -23 |
| EPS Diluted | -2.17 | -1.91 | -1.27 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 19 | 7 | 18 |
| Total Current Assets | 133 | 98 | 93 |
| Total Assets | 134 | 114 | 108 |
| Total Current Liabilities | 9 | 11 | 16 |
| Total Liabilities | 60 | 79 | 87 |
| Total Equity | 74 | 35 | 21 |
| Total Debt | 50 | 70 | 72 |
| Net Debt | 31 | 63 | 54 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -25 | -37 | -20 |
| Capital Expenditure | -0 | -1 | -0 |
| Free Cash Flow | -25 | -37 | -20 |
| Stock-Based Comp | 4 | 8 | 10 |
| Net Change in Cash | -7 | -13 | 11 |